These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 36740347

  • 1. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
    Pittenger C.
    Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
    [Abstract] [Full Text] [Related]

  • 2. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA, Seay SM.
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [Abstract] [Full Text] [Related]

  • 3. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
    Poppe C, Müller ST, Greil W, Walder A, Grohmann R, Stübner S.
    J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW, Morton WA, Lydiard RB.
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL, Jakubovski E, Bloch MH.
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.
    Fineberg NA, Reghunandanan S, Brown A, Pampaloni I.
    Aust N Z J Psychiatry; 2013 Feb; 47(2):121-41. PubMed ID: 23125399
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An update on the pharmacological treatment of obsessive-compulsive disorder.
    Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M.
    Expert Opin Pharmacother; 2007 Apr; 8(5):563-83. PubMed ID: 17376013
    [Abstract] [Full Text] [Related]

  • 10. An updated review of antidepressants with marked serotonergic effects in obsessive-compulsive disorder.
    Pizarro M, Fontenelle LF, Paravidino DC, Yücel M, Miguel EC, de Menezes GB.
    Expert Opin Pharmacother; 2014 Jul; 15(10):1391-401. PubMed ID: 24766145
    [Abstract] [Full Text] [Related]

  • 11. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A, Hollander E.
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [Abstract] [Full Text] [Related]

  • 12. OCD: where the serotonin selectivity story begins.
    Pigott TA.
    J Clin Psychiatry; 1996 Aug; 57 Suppl 6():11-20. PubMed ID: 8647793
    [Abstract] [Full Text] [Related]

  • 13. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G.
    Curr Med Chem; 2018 Aug; 25(41):5647-5661. PubMed ID: 29278206
    [Abstract] [Full Text] [Related]

  • 14. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C, Freeston MH, Borgeat F.
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [Abstract] [Full Text] [Related]

  • 15. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis DA, Rapinesi C, Sani G, Girardi P, Kotzalidis GD, Pompili M.
    Curr Neuropharmacol; 2019 Apr; 17(8):710-736. PubMed ID: 30101713
    [Abstract] [Full Text] [Related]

  • 16. Past, present and future drugs for the treatment of obsessive-compulsive disorder.
    Marazziti D, Consoli G, Baroni S, Catena Dell'Osso M.
    Curr Med Chem; 2010 Apr; 17(29):3410-21. PubMed ID: 20712565
    [Abstract] [Full Text] [Related]

  • 17. Evidence-based pharmacotherapy of obsessive-compulsive disorder.
    Fineberg NA, Gale TM.
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):107-29. PubMed ID: 15450126
    [Abstract] [Full Text] [Related]

  • 18. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J.
    Adv Pharmacol; 1994 Mar; 30():35-52. PubMed ID: 7833296
    [Abstract] [Full Text] [Related]

  • 19. [Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].
    Brochier T, Hantouche E.
    Encephale; 1989 Mar; 15(3):325-33. PubMed ID: 8641159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.